Western European Molecular Imaging Market Analysis 2018-2022: Improvements in Quantitation, New Clinical Applications, and Rising Prevalance of Cancer Keeps Market on the Upward Growth Curve

DUBLIN, Aug. 22, 2018 /PRNewswire/ -- The "Analysis of Western European Molecular Imaging Market, Forecast to 2022" report has been added to ResearchAndMarkets.com's offering.

This study takes a look at the Western European molecular imaging industry. The geographic scope of the market includes the United Kingdom, Germany, Italy, Spain, France, Scandinavia, and Benelux.

The market is expected to experience a compound annual growth rate (CAGR) of 4.5 percent during 2017 to 2022, primarily driven by the growing incidence of cancer - with breast cancer and lung cancer being the most common cancers - and the continuing shift from single modalities to hybrid imaging. France, Germany, and Italy are hotspots for immediate future, followed by the steadily growing markets of Spain, Scandinavia, and Benelux.

Apart from the rising incidence of cancer, the greater availability of novel radiotracers and higher quantitation will drive the molecular imaging market. On the other hand, the price sensitivity of purchasers due to insufficient reimbursement and competition from other imaging modalities will continue to restrain growth.

France is the fastest growing market in Western Europe due to its high gross domestic product (GDP) spending on oncology screening programs. Italy and Germany are expected to be the second and third fastest due to the high incidence of cancer and increasing government initiatives. Spain, Benelux, and Scandinavia are forecast to grow steadily, while the United Kingdom is likely to be the slowest due to budgetary constraints.

There has been greater focus on PET/CT systems over SPECT/CT over the last few years and this trend will continue in the forecast period. Top market participants are anticipated to continue placing greater emphasis on premium modalities.

The PET/CT segment will experience the highest growth, while more stable growth is expected for the SPECT/CT segment. The latter segment has shrunken due to past shortages of Tc-99m, concerns over stability of future supply, improvements in PET MPI, and lower quantitation accuracy than PET. However, over the last few years, improvements in its technology and quantitation accuracy is expected to drive growth.

SPECT/CT has traditionally been used for cardiac imaging, while PET/CT has primarily been used for oncology imaging. This is set to change as advancements in PET/CT and SPECT/CT technologies, coupled with the launch of novel radiopharmaceuticals, will see molecular imaging applied across new clinical areas such as orthopedics and neurology.

Key Topics Covered:

1. Executive Summary

• Key Findings
• Scope of the Study-Molecular Imaging
• Key Questions this Study will Answer
• Market Engineering Measurements-Total Molecular Imaging Market
• Market Engineering Measurements-PET/CT
• Market Engineering Measurements-SPECT/CT
• Market Engineering Measurements-SPECT
• CEO's Perspective
• Executive Summary-3 Big Predictions

2. Scope of the Study

• Scope of this Study
• Molecular Imaging-Definition

3. Market Drivers and Restraints

• Market Drivers
• Drivers Explained
• Market Restraints
• Restraints Explained

4. Forecast and Trends - Total Molecular Imaging Market

• Market Engineering Measurements
• Forecast Assumptions
• Unit Shipment Forecast
• Total Molecular Imaging Market Revenue Forecast
• Revenue Forecast by Segment
• Forecast Discussion
• Percent Revenue Forecast by Country
• Revenue Forecast by Country
• Forecast Discussion

5. Top Global Molecular Imaging Market Trends

• Shift in Focus from Standalone to Hybrid Imaging
• Role of Molecular Imaging in Personalized Medicine
• PET Scanning and Alzheimer's Disease

6. Growth Opportunities and Companies to Action

• 5 Major Growth Opportunities
• Strategic Imperatives for Success and Growth

7. PET/CT Equipment Segment

• Market Engineering Measurements
• Unit Shipment Forecast
• Revenue Forecast
• Forecast Discussion
• Market Share
• Market Share Analysis

8. SPECT/CT Equipment Segment

• Market Engineering Measurements
• Unit Shipment Forecast
• Revenue Forecast
• Forecast Discussion
• Market Share
• Market Share Analysis

9. SPECT Equipment Segment

• Market Engineering Measurements
• Unit Shipment Forecast
• Revenue Forecast
• Forecast Discussion
• Market Share
• Market Share Analysis

10. Germany Breakdown

• Germany Market Analysis
• Unit Shipment Forecast
• Revenue Forecast
• Segment Revenue Forecast
• Forecast Discussion

11. United Kingdom Breakdown

• United Kingdom Market Analysis
• Unit Shipment Forecast
• Revenue Forecast
• Revenue Forecast by Segment
• Forecast Discussion

12. France Breakdown

• France Market Analysis
• Unit Shipment Forecast
• Revenue Forecast
• Segment Revenue Forecast
• Forecast Discussion

13. Spain Breakdown

• Spain Market Analysis
• Unit Shipment Forecast
• Revenue Forecast
• Segment Revenue Forecast
• Forecast Discussion

14. Italy Breakdown

• Italy Market Analysis
• Unit Shipment Forecast
• Revenue Forecast
• Segment Revenue Forecast
• Forecast Discussion

15. Scandinavia Breakdown

• Scandinavia Market Analysis
• Unit Shipment Forecast
• Revenue Forecast
• Segment Revenue Forecast
• Forecast Discussion

16. Benelux Breakdown

• Benelux Market Analysis
• Unit Shipment Forecast
• Revenue Forecast
• Segment Revenue Forecast
• Forecast Discussion

17. The Last Word

• The Last Word-3 Big Predictions
• The Last Word-Discussion
• Legal Disclaimer

18. Appendix

• Market Engineering Methodology
• Installed Base of PET and PET/CT in Total Europe
• Density of PET and PET/CT in Western Europe
• List of Exhibits

Companies Mentioned

• Digirad
• GE Healthcare
• Heatlhineers
• Neusoft
• Philips Healthcare
• Siemens
• Spectrum Dynamics
• Toshiba

For more information about this report visit https://www.researchandmarkets.com/research/lmb6gp/western_european?w=5

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets

Related Links

http://www.researchandmarkets.com